Clinical predictors of stimulant efficacy in adults with ADHD
Therapeutic Advances in Psychopharmacology · 2026-04 · 16
DOI: 10.1177/20451253261428807 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Psychopharmacology, online erschienen am 03.04.2026. Verfasst von Maura DiSalvo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, MA, USA. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIMH NIH HHS, national institutes of health, massachusetts general hospital.
Abstract (Originalsprache)
Background
Attention-deficit/hyperactivity disorder (ADHD) is a disorder marked by inattentiveness and/or hyperactivity and increased impulsivity. A common treatment for ADHD is stimulant medications, with a formulation of methylphenidate or amphetamine. Although stimulant medication is effective in most patients, 40% show no response. There have been attempts to predict stimulant efficacy through neuroimaging and electroencephalograms; however, these methods are expensive and not sustainable in day-to-day clinical practices.
Objectives
This study aimed to identify clinical factors that could be used to predict which patients would best respond to stimulants.
Design
The reporting of this study conforms to the STROBE statement. This was a naturalistic prospective observational study.
Methods
Thirty-six medication-naïve adults with ADHD were prescribed stimulant medication and naturalistically followed for an average of 116 days. Demographics, type of stimulant, and seven clinical rating scales were analyzed to identify response predictors. Truncated Poisson regressions, stepwise logistic regressions, receiver operating characteristic curve analysis, and Bonferroni corrections were performed.
Results
Executive function impairment and better quality of life were found to be the best indicators for stimulant response. Higher scores on Adult Self-Report (ASR) Thought Problems, Withdrawn Problems, Internalizing Problems, and Intrusive Thoughts were indicative of lower stimulant efficacy. Poorer working memory and task monitoring also predicted lower stimulant response.
Conclusion
These clinical measures could aid clinicians and patients in predicting who would better respond to stimulant medications and reduce the time that patients wait before finding an effective treatment. Executive functioning, quality of life, and ASR profile measurements can be used to best manage ADHD symptomology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, MA, USA.
- Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
- McGovern Institute for Brain Research, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA.
- Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, 55 Fruit Street, Warren 628, Boston, MA 02114, USA.
ORCID-Profile: Mai Uchida
Förderung
- NIMH NIH HHS
- national institutes of health
- massachusetts general hospital
Zitieren
APA
DiSalvo, M., Biederman, J., O'Connor, H., Iorini, M., Green, A., Woodworth, K. Y., Wozniak, J., Joshi, G., Gabrieli, J., & Uchida, M. (2026). Clinical predictors of stimulant efficacy in adults with ADHD. Therapeutic Advances in Psychopharmacology, 16. https://doi.org/10.1177/20451253261428807
Vancouver
DiSalvo M, Biederman J, O'Connor H, Iorini M, Green A, Woodworth KY, et al. Clinical predictors of stimulant efficacy in adults with ADHD. Therapeutic Advances in Psychopharmacology. 2026;16. doi:10.1177/20451253261428807
BibTeX
@article{DiSalvo2026,
author = {DiSalvo, Maura and Biederman, Joseph and O'Connor, Hannah and Iorini, Maria and Green, Allison and Woodworth, K Yvonne and Wozniak, Janet and Joshi, Gagan and Gabrieli, John and Uchida, Mai},
title = {Clinical predictors of stimulant efficacy in adults with ADHD},
journal = {Therapeutic Advances in Psychopharmacology},
year = {2026},
volume = {16},
doi = {10.1177/20451253261428807}
}
EUVIMED